Trial Parameters
Condition Cardiovascular Diseases
Sponsor Hospital Israelita Albert Einstein
Study Type OBSERVATIONAL
Phase N/A
Enrollment 90
Sex FEMALE
Min Age 25 Years
Max Age 45 Years
Start Date 2024-08-22
Completion 2025-12-30
Interventions
Hormonal implantControl group
Brief Summary
The purpose of this study is to assess the association of hormonal implant with gestrinone in cardiovascular health outcomes in young women.
Eligibility Criteria
Inclusion Criteria: * Women; * Between 25 and 45 years age; * History of ≥ 1 hormonal implant with gestrinone in the last 6 months or never had used any hormonal implants. Exclusion Criteria: * Pregnancy; * Menopause; * Smoking; * Moderate-high consumption of alcoholic beverages (above 14 drinks per week); * Previous cardiovascular event (e.g. myocardial infarction and stroke); * Uncontrolled psychiatric disease; * Ventricular arrhythmia; * Using antibiotics or corticoids; * Regular contraceptive use (estrogen and progesterone); * Use of illicit drugs.
Related Trials
NCT05943821
The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk
View Trial →
NCT04055428
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals
View Trial →
NCT06826872
Efficacy and Safety of SPC1001 in Patients With Essential Hypertension
View Trial →